We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The reclassification of Eyenovia’s product came in a complete response letter the FDA sent the company Oct. 22 over its ophthalmic new drug application. Read More
Samples for the test are either self-collected, or collected by an assisting adult, from people age 14 and up with symptoms of COVID-19 within seven days of symptom onset. Read More
Luminopia One allows patients to watch “therapeutically modified” TV shows and movies to improve their vision, while using a virtual reality headset. Read More
Thermo Fisher’s SDNA saliva collection devices protect DNA and RNA transcripts postcollection to help ensure accurate test results from 2 mm of saliva. Read More
When used together with the companion test, treatment with Opdivo in combination with chemotherapy shows superior overall survival and progression-free survival compared to chemotherapy alone, the company said. Read More